Clinical trials
Phase 2 Vision Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 1 |
| 2011 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Active, not recruiting | 2 |
| Withdrawn | 2 |
| Unknown status | 1 |
| Recruiting | 1 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Laboratoires Thea | 3 |
| Novartis Pharmaceuticals | 3 |
| McMaster University | 1 |
| University Health Network, Toronto | 1 |
| University Hospital Tuebingen | 1 |
| University of California, San Francisco | 1 |
| Vitreous -Retina- Macula Consultants of New York | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vision Disorders | 11 |
| Macular Degeneration | 5 |
| Wet Macular Degeneration | 4 |
| Retinal Diseases | 3 |
| Retinitis Pigmentosa | 3 |
| Usher Syndromes | 3 |
| Eye Abnormalities | 2 |
| Eye Diseases, Hereditary | 2 |
| Geographic Atrophy | 2 |
| Bardet-Biedl Syndrome | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.